Baidu
map

读图与图谱

订阅

MedSci主页 / 所有栏目 / 读图与图谱

读图：痛风的预防和治疗

2016-02-23 医学美图 医学美图

痛风治疗
关注


版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=65425, encodeId=e3776542528, content=注意饮食, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Wed Feb 24 17:02:00 CST 2016, time=2016-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65269, encodeId=658165269c4, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Feb 23 14:27:00 CST 2016, time=2016-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65252, encodeId=05a36525222, content=很痛, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40251618559, createdName=2014lb3, createdTime=Tue Feb 23 11:25:00 CST 2016, time=2016-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65237, encodeId=ba056523e59, content=痛风很痛, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Tue Feb 23 10:57:00 CST 2016, time=2016-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65238, encodeId=79fb65238e7, content=痛风很痛, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Tue Feb 23 10:57:00 CST 2016, time=2016-02-23, status=1, ipAttribution=)]
    2016-02-24 老段

    注意饮食

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=65425, encodeId=e3776542528, content=注意饮食, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Wed Feb 24 17:02:00 CST 2016, time=2016-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65269, encodeId=658165269c4, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Feb 23 14:27:00 CST 2016, time=2016-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65252, encodeId=05a36525222, content=很痛, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40251618559, createdName=2014lb3, createdTime=Tue Feb 23 11:25:00 CST 2016, time=2016-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65237, encodeId=ba056523e59, content=痛风很痛, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Tue Feb 23 10:57:00 CST 2016, time=2016-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65238, encodeId=79fb65238e7, content=痛风很痛, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Tue Feb 23 10:57:00 CST 2016, time=2016-02-23, status=1, ipAttribution=)]
    2016-02-23 忠诚向上

    好好学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=65425, encodeId=e3776542528, content=注意饮食, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Wed Feb 24 17:02:00 CST 2016, time=2016-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65269, encodeId=658165269c4, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Feb 23 14:27:00 CST 2016, time=2016-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65252, encodeId=05a36525222, content=很痛, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40251618559, createdName=2014lb3, createdTime=Tue Feb 23 11:25:00 CST 2016, time=2016-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65237, encodeId=ba056523e59, content=痛风很痛, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Tue Feb 23 10:57:00 CST 2016, time=2016-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65238, encodeId=79fb65238e7, content=痛风很痛, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Tue Feb 23 10:57:00 CST 2016, time=2016-02-23, status=1, ipAttribution=)]
    2016-02-23 2014lb3

    很痛

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=65425, encodeId=e3776542528, content=注意饮食, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Wed Feb 24 17:02:00 CST 2016, time=2016-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65269, encodeId=658165269c4, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Feb 23 14:27:00 CST 2016, time=2016-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65252, encodeId=05a36525222, content=很痛, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40251618559, createdName=2014lb3, createdTime=Tue Feb 23 11:25:00 CST 2016, time=2016-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65237, encodeId=ba056523e59, content=痛风很痛, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Tue Feb 23 10:57:00 CST 2016, time=2016-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65238, encodeId=79fb65238e7, content=痛风很痛, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Tue Feb 23 10:57:00 CST 2016, time=2016-02-23, status=1, ipAttribution=)]
    2016-02-23 wei834766788

    痛风很痛

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=65425, encodeId=e3776542528, content=注意饮食, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Wed Feb 24 17:02:00 CST 2016, time=2016-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65269, encodeId=658165269c4, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Feb 23 14:27:00 CST 2016, time=2016-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65252, encodeId=05a36525222, content=很痛, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40251618559, createdName=2014lb3, createdTime=Tue Feb 23 11:25:00 CST 2016, time=2016-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65237, encodeId=ba056523e59, content=痛风很痛, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Tue Feb 23 10:57:00 CST 2016, time=2016-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65238, encodeId=79fb65238e7, content=痛风很痛, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Tue Feb 23 10:57:00 CST 2016, time=2016-02-23, status=1, ipAttribution=)]
    2016-02-23 wei834766788

    痛风很痛

    0

相关资讯

FDA批准阿斯利康痛风药物Lesinurad治疗痛风相关高尿酸血症

FDA批准阿斯利康痛风药物 Lesinurad(Zurampic) （200mg/d）与黄嘌呤氧化酶抑制剂 (XOI)一起用于治疗痛风相关高尿酸血症。Lesinurad 可尿酸的排泄，减少其生成。控制高尿酸血症是痛风长期治疗的重中之重，Zurampic为数百万一生中可能出现痛风的人群提供了一种新的治疗选择。痛风表现为突然发生的关节剧烈疼痛和肿胀，最常见于大脚趾。在美国有160万名痛风患者，其中85

中国科学家发现与汉族男性痛风相关的基因变异

青岛大学医学院附属医院李长贵教授在Scientific Reports上发表了一篇论文称，他们鉴定出了一个与中国汉族男性痛风发作风险相关基因的单核苷酸多态性。IL-23R基因的rs10889677突变可能导致了汉族男性的痛风病情的发展。痛风是一种炎症性的关节炎，由于尿酸水平升高带来的尿酸单钠结晶会沉淀在关节中，从而带来反复发作的急性疼痛。同时，痛风属于一种自身免疫性疾病。然而，痛风的发病率在不同的

ACR：风湿病和痛风指南更新要点

Normal 0 10 pt 0 2 false false false EN-US ZH-CN X-NONE

重磅炸弹！FDA委员会通过了用于痛风治疗的新药——lesinurad

FDA委员会通过了用于痛风治疗的新药——lesinurad 近日，FDA委员会以10：4的结果通过了lesinurad（200 mg/d）用于治疗痛风相关的高尿酸血症，可联合黄嘌呤氧化酶抑制剂（XOLs）共同用药。Sean Bohen博士，全球药物开发执行副总裁和首席医疗官，认为委员会推荐lesinurad用于痛风的治疗是个令人激动的进步。他期待这能为痛风的治疗提供一种新的治疗方法：当与黄嘌呤氧化

一图读懂：喝咖啡的好处

Medicine：痛风患者发生抑郁障碍的风险较高

抑郁障碍患者的代谢异常比较常见。然而，痛风和抑郁症之间的关系尚不清楚。研究者探讨了痛风，抗痛风的药物和抑郁障碍发生的相关风险的关系。这项队列研究中，研究者从国家健康保险研究数据库招募了34050例痛风患者为痛风组，68100例（无痛风）的对照组，收集样本的数据。研究主要终点为，随访期间抑郁症的诊断。对所有受试者进行随访至诊断为抑郁症，从研究中退出或者研究结束。应用卡方检验分析分类变量和t检验分析连

Baidu
map
Baidu
map
Baidu
map